TCRT (STOCKS)
Alaunos Therapeutics, Inc. Common Stock
$2.140000
+0.150000 (+7.54%)
Prev close: $1.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Holger Weis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4.71M
- Employees
- 1
- P/E (TTM)
- -0.92
- P/B (TTM)
- 3.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $3.00K |
| Operating Expenses | $4.15M |
| Research and Development | $1.44M |
| Other Operating Expenses | $2.71M |
| Operating Income/Loss | -$4.15M |
| Income/Loss From Continuing Operations After Tax | -$4.11M |
| Income/Loss From Continuing Operations Before Tax | -$3.21M |
| Net Income/Loss | -$4.11M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$4.11M |
| Net Income/Loss Available To Common Stockholders, Basic | -$4.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $235.00K |
| Preferred Stock Dividends And Other Adjustments | $235.00K |
| Basic Earnings Per Share | -$2.13 |
| Diluted Earnings Per Share | -$2.13 |
| Basic Average Shares | 5,933,598 |
| Diluted Average Shares | 5,933,598 |
| Assets | $1.88M |
| Current Assets | $970.00K |
| Accounts Receivable | $0.00 |
| Noncurrent Assets | $913.00K |
| Fixed Assets | $82.00K |
| Other Non-current Assets | $831.00K |
| Liabilities | $595.00K |
| Current Liabilities | $595.00K |
| Accounts Payable | $400.00K |
| Other Current Liabilities | $195.00K |
| Noncurrent Liabilities | $0.00 |
| Equity | $1.29M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.29M |
| Liabilities And Equity | $1.88M |
| Net Cash Flow From Operating Activities | -$3.13M |
| Net Cash Flow From Operating Activities, Continuing | -$3.13M |
| Net Cash Flow | $35.00K |
| Net Cash Flow, Continuing | $35.00K |
| Comprehensive Income/Loss | -$4.11M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$4.11M |
| Other Comprehensive Income/Loss | $0.00 |